Skip to main content
. Author manuscript; available in PMC: 2015 Nov 16.
Published in final edited form as: Pediatr Blood Cancer. 2013 Mar 22;60(9):1411–1417. doi: 10.1002/pbc.24532

Fig. 5.

Fig. 5

Kaplan–Meier curves depicting (A) event-free and (B) overall survival in years following diagnosis based on molecular classification of disease as being ERMS (n = 261), ARMSn (n = 11), ARMS PF3+ (n = 57), or ARMS PF7+ (n = 11) within the subset of patients with Stage 2, 3 and Group III disease. P < 0.001 (A) and 0.0054 (B).